Of HMI. During the Term, so long as HMI is the Commercializing Party for the U.S. [***] Product and subject to Article 8 (Manufacturing and Technology Transfer), HMI will [***] Commercialize each In-Vivo [***] Product in the U.S. following the receipt of Marketing Approval from the FDA in the U.S. for such In-Vivo [***] Product.
Appears in 3 contracts
Samples: Collaboration and License Agreement (Homology Medicines, Inc.), Collaboration and License Agreement (Homology Medicines, Inc.), Collaboration and License Agreement (Homology Medicines, Inc.)
Of HMI. During the Term, so long as HMI is the Commercializing Party for the U.S. [***] Product Products and subject to Article 8 (Manufacturing and Technology Transfer), HMI will [***] Commercialize each be solely responsible, at its cost and expense, for Commercializing all In-Vivo [***] Product Products in the U.S. following the receipt of Marketing Approval from the FDA in the U.S. (including booking all sales for such In-Vivo [***] ProductProducts in the U.S.).
Appears in 3 contracts
Samples: Collaboration and License Agreement (Homology Medicines, Inc.), Collaboration and License Agreement (Homology Medicines, Inc.), Collaboration and License Agreement (Homology Medicines, Inc.)